DA
MEDP icon

Duality Advisers’s Medpace MEDP Stock Holding History

Duality Advisers’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-6,624
Closed -$2.68M – 325
2024
Q1 		$2.68M Buy
6,624
+11
+0.2% +$3.87K 0.26% 126
2023
Q4 		$2.03M Buy
6,613
+5,768
+683% +$1.56M 0.21% 169
2023
Q3 		$205K Sell
845
-6,896
-89% -$1.76M 0.02% 524
2023
Q2 		$1.86M Buy
7,741
+3,876
+100% +$805K 0.23% 168
2023
Q1 		$727K Sell
3,865
-6,112
-61% -$1.26M 0.08% 350
2022
Q4 		$2.12M Buy
+9,977
New +$1.99M 0.24% 143
2022
Q3 		– Sell
-5,179
Closed -$775K – 660
2022
Q2 		$775K Buy
+5,179
New +$750K 0.08% 405

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

Duality Advisers's MEDP Position: Q2 2024 in Review

Duality Advisers sold out of Medpace (MEDP) in Q2 2024, closing a stake of 6,624 shares — an estimated $2.68M sold.

Duality Advisers first reported a position in MEDP in Q2 2022 and held it in 7 quarters. The position peaked at $2.68M in Q1 2024. 623 funds tracked by Wall St. Rank hold MEDP as of Q2 2024.

  • Duality Advisers reported no remaining Medpace position as of Q2 2024 after selling out during the quarter.
  • Duality Advisers sold 6,624 Medpace shares in Q2 2024, an estimated $2.68M.
  • Duality Advisers first reported a position in Medpace in Q2 2022 and held it in 7 quarters.
  • Duality Advisers's Medpace position peaked at $2.68M in Q1 2024.
  • 623 funds tracked by Wall St. Rank held Medpace as of Q2 2024.

Based on Duality Advisers's 13F filing for Q2 2024.